# Aligos Therapeutics, Inc.: Form SCHEDULE 13D/A, filed Mar 12, 2025

- Company: [Aligos Therapeutics, Inc.](/companies/algs.md) (CIK 1799448)
- Form: SCHEDULE 13D/A
- Filed: 2025-03-12
- Accepted by EDGAR: Mar 12, 2025, 20:30 ET
- Period: not reported
- Accession: 0000950170-25-038262
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1799448/000095017025038262/xslSCHEDULE_13D_X01/primary_doc.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1799448/000095017025038262/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1799448/000095017025038262/xslSCHEDULE_13D_X01/primary_doc.xml

Filed Mar 12, 2025.
Source: SEC EDGAR, the filing index for accession 0000950170-25-038262. Last ingested by Listed: Oct 24, 2026, 15:07 ET. No prices; not investment advice.